Articles by Disease (Parkinsonian Disorders)

Lipid Nanocarriers for Neurotherapeutics: Introduction, Challenges, Blood-brain Barrier, and Promises of Delivery Approaches

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 21
Page: 952-965
Author(s): Mohammed Aslam, Md. Noushad Javed*, Hala Hasan Deeb, Michel Kaisar Nicola, Mohd. Aamir Mirza, Md. Sabir Alam, Md. Habban Akhtar and Aafrin Waziri

A Comprehensive Review on Preclinical Evidence-based Neuroprotective Potential of Bacopa monnieri against Parkinson's Disease

Journal: Current Drug Targets
Volume: 23
Page: 889-901
Author(s): Ahsas Goyal*, Sainu Gopika, Abhishek Kumar and Debapriya Garabadu

Evaluation of Venom as a Promising Tool for Drug Discovery: Focusing on Neurological Disorders

Journal: Venoms and Toxins
Volume: 2
Page: 6-14
Author(s): Soodeh Omidi, Masoumeh Mehrpouya, Morteza Oladnabi*, Abbas Azadmehr, Fatemeh Kazemi-Lomedasht and Najmeh Yardehnavi*

COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 21
Page: 818-829
Author(s): Adejoke Onaolapo* and Olakunle Onaolapo*

A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders

Journal: Current Drug Targets
Volume: 23
Page: 729-751
Author(s): Bhupinder Kumar, Naveen Kumar, Amandeep Thakur, Vijay Kumar, Rakesh Kumar* and Vinod Kumar*

How to Optimize the Effectiveness and Safety of Parkinson’s Disease Therapy? – A Systematic Review of Drugs Interactions with Food and Dietary Supplements

Journal: Current Neuropharmacology
Volume: 20
Page: 1427-1447
Author(s): Wiesner Agnieszka, Paśko Paweł and Kujawska Małgorzata*

Tremor and Rigidity in Patients with Parkinson’s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 21
Page: 596-609
Author(s): Shivam Kumar, Lav Goyal and Shamsher Singh*